Surgical Management of Breast Cancer Liver Metastasis.
Breast cancer liver metastasis
Liver metastasectomy
Liver resection
Metastatic breast cancer
Journal
Surgical oncology clinics of North America
ISSN: 1558-5042
Titre abrégé: Surg Oncol Clin N Am
Pays: United States
ID NLM: 9211789
Informations de publication
Date de publication:
01 2021
01 2021
Historique:
entrez:
22
11
2020
pubmed:
23
11
2020
medline:
1
12
2021
Statut:
ppublish
Résumé
Hepatic resection for patients with isolated breast cancer liver metastases (BCLM) is associated with prolonged disease-free interval and better overall survival in highly selected patients. Patients with limited disease who are not candidates for surgery benefit from ablative therapies for isolated breast cancer metastasis in addition to systemic chemotherapy. In the era of modern effective systemic chemotherapy for BCLM, local regional therapies are warranted, yet only in well-selected patients following discussion in a multidisciplinary setting. This article reviews data related to hepatic resection and ablative therapies of BCLM, as well as long-term outcomes of women treated with these approaches.
Identifiants
pubmed: 33220807
pii: S1055-3207(20)30080-6
doi: 10.1016/j.soc.2020.09.003
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
27-37Informations de copyright
Copyright © 2020 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Disclosure The authors have nothing to disclose.